Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0034 CHF | 0.00% | -10.53% | +750.00% |
Mar. 28 | Swiss Exchange Regulator Drops Inquiry Into Kinarus Therapeutics | MT |
Feb. 06 | Kinarus Therapeutics Receives Swiss Court Approval for Revocation of Bankruptcy | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Bausch
CEO | Chief Executive Officer | - | - |
Claudia Berger
CTO | Chief Tech/Sci/R&D Officer | - | - |
Matthew Wright
COO | Chief Operating Officer | - | - |
Thierry Fumeaux
CTO | Chief Tech/Sci/R&D Officer | - | - |
Stephane Pinto
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alexander Bausch
CEO | Chief Executive Officer | - | - |
Hari Kumar
CHM | Chairman | 69 | - |
Director/Board Member | 59 | - | |
Eugene Tierney
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,310,175,889 | 739,643,734 ( 56.45 %) | 8,398,873 ( 0.6410 %) | 56.45 % |
Company contact information
Kinarus Therapeutics Holding AG
Technologiepark Basel Hochbergerstrasse 60C
4057, Basel
+
http://www.kinarus.comSector
1st Jan change | Capi. | |
---|---|---|
+750.00% | 3.99M | |
-26.82% | 1.85B | |
+33.40% | 296M | |
-14.55% | 81.24M | |
-46.22% | 65.82M |
- Stock Market
- Equities
- KNRS Stock
- Company Kinarus Therapeutics Holding AG